Breaking News
Get 45% Off 0
🚨 Don’t miss your updated list of AI-picked stocks for this month
Pick Stocks with AI

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
Why TJX (TJX) Is A Great Dividend Stock Right Now By Zacks Investment Research - Mar 16, 2020

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is...

Coupa Software (COUP) Q4 Earnings, Revenues Top Estimates By Zacks Investment Research - Mar 16, 2020

Coupa Software Inc. (NASDAQ:COUP) reported fourth-quarter fiscal 2020 non-GAAP earnings of 21 cents per share that surpassed the Zacks Consensus Estimate of 5 cents. Further, the bottom line soared...

MGP Or VTR: Which Is The Better Value Stock Right Now? By Zacks Investment Research - Mar 16, 2020

Investors with an interest in REIT and Equity Trust - Other stocks have likely encountered both MGM Growth Properties (MGP) and Ventas (VTR). But which of these two stocks presents investors with the...

XPO Or ZTO: Which Is The Better Value Stock Right Now? By Zacks Investment Research - Mar 16, 2020

Investors looking for stocks in the Transportation - Services sector might want to consider either XPO Logistics (XPO) or ZTO Express (Cayman) Inc. (ZTO). But which of these two stocks presents...

Arthur J. Gallagher Strengthens Portfolio With MMT Buyout By Zacks Investment Research - Mar 16, 2020

Arthur J. Gallagher & Co. (NYSE:AJG) has closed the buyout of McConnell, Manit & Trout Insurance Services, LLC (MMT). The details of the transaction were not made public.Founded in 2013, MMT...

Catalyst's (CPRX) Q4 Earnings Miss Estimates, Revenues Meet By Zacks Investment Research - Mar 16, 2020

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) reported earnings of 7 cents per share in the fourth quarter of 2019, missing the Zacks Consensus Estimate of 9 cents. Meanwhile, the company reported a...

Southwest Withdraws 2020 View On Coronavirus-Led Low Demand By Zacks Investment Research - Mar 16, 2020

Southwest Airlines Co. (NYSE:LUV) has withdrawn its 2020 guidance as coronavirus concerns are evolving and weighing heavily on air travel demand. The company is seeing a massive fall in passenger...

Lilly's Olumiant Gets Breakthrough Therapy Tag For Hair Loss By Zacks Investment Research - Mar 16, 2020

Eli Lilly (NYSE:LLY) announced that the FDA has granted Breakthrough Therapy designation to its oral JAK inhibitor, Olumiant (baricitinib) as a treatment for alopecia areata (“AA”), an...

Continue with Apple
Continue with Google
or
Sign up with Email